Dabigatran DM+D



Codelist metadata

Coding system

Dictionary of Medicines and Devices

Coding system release

unknown

Organisation

OpenSAFELY

Codelist ID

opensafely/dabigatran-dmd

Version ID

6c39d1bf

Versions

About

Description

This is a codelist that identifies all preparations from the NHS dictionary of medicines and devices for dabigatran etexilate , one of the Directing Oral Anticoagulants which are often referred to as DOACs.

Methodology

All preparations beginning with the following BNF code 0208020X0 were identified and mapped dm+d products for these were included. https://github.com/opensafely/codelist-development/issues/59

Signed off by

  • Richard Croker, (Feb. 22, 2021)
  • Vicky Speed, (Feb. 22, 2021)

Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.

We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.

* dm+d codelists can be downloaded with codes mapped to changed VMPs included - this is the default for an OpenSAFELY project. See the documentation on keeping codelists up to date for more details.

dmd_type dmd_id dmd_name bnf_code
VMP 13532911000001104 Dabigatran etexilate 75mg capsules 0208020X0AAAAAA
VMP 13532811000001109 Dabigatran etexilate 110mg capsules 0208020X0AAABAB
VMP 19469811000001101 Dabigatran etexilate 150mg capsules 0208020X0AAACAC
AMP 13504711000001102 Pradaxa 75mg capsules 0208020X0BBAAAA
AMP 13505411000001109 Pradaxa 110mg capsules 0208020X0BBABAB
AMP 19465811000001104 Pradaxa 150mg capsules 0208020X0BBACAC

* Note that this is the full list of explicitly included dm+d codes for this codelist. An OpenSAFELY project will by default also include previous or subsequent codes for any included VMPs that may have changed code. See the documentation on keeping codelists up to date for more details.